Skip to main content
Caplight Logo









CritiTech

CritiTech

Private
Lawrence, KansasHealthcare & Life Scienceshttps://crititech.com

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CritiTech operates in Healthcare & Life Sciences and is based in Lawrence, Kansas. It was founded in 2001.

CritiTech is a pharmaceuticals company that provides contract development and manufacturing organization (CDMO) services for drug development through particle engineering.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CritiTech Comparables

Compare CritiTech with similar companies based on industry and business-model similarity.

CritiTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Codis
86%
Serán Bioscience
84%
Bend Bioscience
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CritiTech Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for CritiTech. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Matthew McClorey

President And CEO

Executive Team

Jody Schrandt

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 31% MoM.

  • May 4, 2025

    Monthly visitors grew 118% MoM, reaching 2.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

CritiTech Filings

Explore SEC and related filing metadata, where available.

CritiTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CritiTech's valuation, stock price, and market status.

Is CritiTech a public or private company?

CritiTech is a private company.

What is the current stock price of CritiTech?

CritiTech is a private company, so its shares have no public market price. Caplight tracks CritiTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CritiTech worth (valuation)?

Valuation information for CritiTech is not publicly available.

Can I buy CritiTech stock?

CritiTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CritiTech's last funding round?

Funding round information for CritiTech is not publicly available.

Who are the main investors in CritiTech?

Investor information for CritiTech is not publicly disclosed.

Will CritiTech IPO soon?

No public IPO plans have been announced for CritiTech.

How can I track CritiTech secondary market activity?

Caplight tracks bids, offers, and trades in CritiTech's shares on secondary markets.

Firmographic Details

HeadquartersLawrence, Kansas
Employee Range16
Year Founded2001
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?